KC53: Adult Screening Programmes: Cervical Screening

This return is in development by the NHS Cancer Screening Programme, therefore the information should not be used.
For the latest version of the form and further details, please see the Health and Social Care Information Centre website.For the latest version of the form and further details, please see the Health and Social Care Information Centre website.

• Contextual Overview

• The Department of Health, NHS Cervical Screening Programme (NHSCSP) and Strategic Health Authorities require information from Primary Care Trusts on Cervical Screening.

• The information helps to monitor the process of achieving the Government's target to reduce the incidence of invasive cervical cancer and to ensure that the screening programme is managed effectively. It is used to monitor coverage by the cervical screening programme of the eligible Primary Care Trust responsible population.

• Information on the return is also used in Public Expenditure Survey (PES) negotiations, resource allocation to the NHS and Departmental accountability.

• Information based on the KC53 return is published annually by the Department in the Statistical Bulletin `Cervical Screening Programme'.

  Completing Return KC53: Cervical Screening Programme

• The Cervical Screening Programme is a programme to deliver services within a 'structured framework' to a defined target population, planned by a Primary Care Trust. The services provided to the population under this programme may be carried out by one or more Health Care Providers - NHS Trust, general medical practitioner (GMP), private or voluntary organisation or any combination of these.

• Information on Cervical Screening should be readily available from the call and recall service's computerised call and recall system.

• The return requires the ORGANISATION CODE and ORGANISATION NAME of the Primary Care Trust. It requires information about women (PERSONS) on the lists of GPs in the Primary Care Trust and women from the unregistered population who live in the geographical area for which the Primary Care Trust is responsible at 31 March. It is completed annually and submitted within two months of this date.

KC53: Adult Screening Programmes: Cervical Screening

This return is in development by the NHS Cancer Screening Programme, therefore the information should not be used.
For the latest version of the form and further details, please see the Health and Social Care Information Centre website.For the latest version of the form and further details, please see the Health and Social Care Information Centre website.

• Part F: Cervical Screening Programme - Test Recall/Status of women following most severe screening result in the year

• This part of the return collects information about the action taken following a woman's most severe test result in a year.

• The women included are those who have had a Screening Test and are aged 20 to 64. The age is derived from the PERSON BIRTH DATE.

  A Screening Test is a CLINICAL INTERVENTION where the CLINICAL INTERVENTION TYPE is National Code 'Screening Test'.

• The data are based on the results of the woman's most severe test in the year and relate to Screening Tests with a Screening Test Date between 1 April - 31 March. Classifications are those of CYTOLOGY RESULT TYPE of a Request for Pathology Investigation and are in accordance with the categories shown in box 22 of HMR 101/5 Request/Report for Cervical or Vaginal Cytology.

  Screening Test Date is the same as attribute ACTIVITY DATE where the ACTIVITY DATE TYPE is National Code 'Screening Test Date'. A Request for Pathology Investigation is a DIAGNOSTIC TEST REQUEST where the DIAGNOSTIC TEST REQUEST TYPE is National Code 'Request for Pathology Investigation.'

  Woman's most severe test result in the year

• This is classified by the following CYTOLOGY RESULT TYPES:

  Inadequate (cat. 1)
  Negative (cat. 2)
  Mild dyskaryosis (cat. 3)
  Severe dyskaryosis (cat. 4)
  Severe dyskaryosis/?invasive carcinoma (cat. 5)
  ?Glandular neoplasia (cat. 6)
  Moderate dyskaryosis (cat. 7)
  Borderline changes (cat. 8)

• The return requires a count of the CYTOLOGY SCREENING ACTION TYPE against each CYTOLOGY RESULT TYPE. The actions are classified into:

  Normal (A) -	Standard Primary Care Trust recall interval (Normal) (A)
  Suspend (S) -	Refer for medical assessment or under medical treatment (Suspend) (S)
  Repeat (R) -	Repeat at interval specified (R)

• The actions are based on result codes 1 to 8 from HMR 101/5, the operational document used by most laboratories for coding the results of cervical smears.

KC53: Adult Screening Programmes: Cervical Screening

This return is in development by the NHS Cancer Screening Programme, therefore the information should not be used.
For the latest version of the form and further details, please see the Health and Social Care Information Centre website.For the latest version of the form and further details, please see the Health and Social Care Information Centre website.

• Part A: Cervical Screening Programme - Status of PCT Responsible Population

  Part A1

• Part A1 of KC53 requires information on the routine recall interval in force in the Primary Care Trust for the Screening Programme. This is the CERVICAL SCREENING RECALL INTERVAL.

  A Screening Programme is a HEALTH PROGRAMME where the HEALTH PROGRAMME TYPE is National Code 06 'Screening Programme'.

  Part A2

• Part A2 of KC53 requires information on the SCREENING STATUS of the Screening Population - the number of women in Primary Care Trusts responsible population at 31 March.

  Screening Population is a HEALTH PROGRAMME POPULATION where the HEALTH PROGRAMME TYPE is National Code 06 'Screening Programme'.

  Age of woman at 31 March (column 1)

• The age bands are derived from the PERSON BIRTH DATE.

  Under 20 (line 0001)
  20-24 (line 0002)
  25-29 (line 0003)
  30-34 (line 0004)
  35-39 (line 0005)
  40-44 (line 0006)
  45-49 (line 0007)
  50-54 (line 0008)
  55-59 (line 0009)
  60-64 (line 0010)
  65-69 (line 0011)
  70-74 (line 0012)
  75-79 (line 0013)
  80 & over (line 0014)

  Number of women resident in Primary Care Trust responsible population (column 2)

• This is the total number of women of all ages derived from the registers maintained by the Primary Care Trust to ensure compatibility with the other data recorded on the return.

  The responsible population includes:

  • all patients on the lists of the GPs in the Primary Care Trust;

  and

  • the unregistered population who live within the geographical area for which the Primary Care Trust is responsible.

  Number of women recorded as having recall ceased (columns 3, 4 and 5)

• These columns do not include women with the SCREENING STATUS classification of Recall suspended.

• Column 3 counts women in the Screening Programme with the SCREENING STATUS classification of Recall ceased - clinical reasons. Women no longer eligible for screening due to removal of the cervix are included.

• Column 4 counts the number of women with the SCREENING STATUS classification of Recall ceased - age reasons, and column 5 counts those with the classification of Recall ceased - other reasons.

  Eligible population (column 6)

• This is calculated by subtracting the number of women in column 3 (i.e. women with the SCREENING STATUS classification of Recall ceased - clinical reasons) from the number in column 2 (i.e. the Primary Care Trust responsible population).

  Number of women whose most recent test was no more than 5 years ago (column 7)

• This is calculated from the addition of columns (2) to (5) in part A3.

  Coverage (%) - less than 5 years since last adequate test (column 8)

• This is calculated from columns (6) and (7) in Part A2.

  Target Age Group (25-64) (line 0015)

• This counts the number of women in the Screening Programme aged between 25 and 64 on 31 March (sum of lines 0003 to 0010). Coverage of the Screening Programme is based on women aged 25 to 64, and not on the NHS Cervical Screening Programme's target population of women aged 20 to 64 who are eligible to receive screening test invitations.

  Total all ages (line 9999)

• This is the total for all age groups counted in lines 0001 to 0014 for each category of women.

KC53: Adult Screening Programmes: Cervical Screening

This return is in development by the NHS Cancer Screening Programme, therefore the information should not be used.
For the latest version of the form and further details, please see the Health and Social Care Information Centre website.For the latest version of the form and further details, please see the Health and Social Care Information Centre website.

• Part A3: Cervical Screening Programme - Screening Status of Eligible Women at 31 March YYYY

• This part of the return collects information specifically about the number of women screened by time since their last test. It includes all women who have had a Screening Test at any time during their life, even if the test was not part of a call and recall system, but was taken opportunistically. It does not include inadequate tests.

  A Screening Test is a CLINICAL INTERVENTION where the CLINICAL INTERVENTION TYPE is National Code 'Screening Test'.

Age of women at 31 March (column 1)

• The age bands are derived from the PERSON BIRTH DATE.

  Under 20 (line 0001)
  20-24 (line 0002)
  25-29 (line 0003)
  30-34 (line 0004)
  35-39 (line 0005)
  40-44 (line 0006)
  45-49 (line 0007)
  50-54 (line 0008)
  55-59 (line 0009)
  60-64 (line 0010)
  65-69 (line 0011)
  70-74 (line 0012)
  75-79 (line 0013)
  80 & over (line 0014)

  Number of women whose most recent adequate test was in last 1.5 years (column 2)

  Number of women whose most recent adequate test was more than 1.5 years but no more than 3 years ago (column 3)

  Number of women whose most recent adequate test was more than 3 years but no more than 3.5 years ago (column 4)

  Number of women whose most recent adequate test was more than 3.5 years but no more than 5 years ago (column 5)

  Number of women whose most recent adequate test was more than 5 years but no more than 10 years ago (column 6)

  Number of women whose most recent adequate test was more than 10 years but no more than 15 years ago (column 7)

  Number of women whose most recent adequate test was more than 15 years ago (column 8)

• The Screening Test Date should be used to derive the count of women tested in the time periods required by the return.

  The Screening Test Date is the same as attribute ACTIVITY DATE where ACTIVITY DATE TYPE is National Code 'Screening Test Date'. 

Women called but no adequate smear (column 9)

• This is a count of the number of women who have been invited at any time in their lives but have no adequate smear.

  Women called but never attended (column 10)

• This is a count of the number of women who have been invited at any time in their lives but have never attended.

  Number of women with no cytology record (column 11)

• This is a count of women in the Primary Care Trust responsible population with no cervical screening history.
  
  The responsible population includes:

  • all patients on the lists of the GPs in the Primary Care Trust;

  and

  • the unregistered population who live within the geographical area for which the Primary Care Trust is responsible.

  Target Age Group (25-64) (line 0015)

• This counts the number of women in the Screening Programme aged between 25 and 64 on 31 March (sum of lines 0003 to 0010). Coverage of the Screening Programme is based on women aged 25 to 64, and not on the NHS Cervical Screening Programme's target population of women aged 20 to 64 who are eligible to receive Screening Test Invitations.

  A Screening Programme is a HEALTH PROGRAMME where the HEALTH PROGRAMME TYPE is National Code 'Screening Programme'.

  Total all ages (line 9999)

• This is the total for all age groups counted in lines 0001 to 0014 for each category of women.

KC53: Adult Screening Programmes: Cervical Screening

This return is in development by the NHS Cancer Screening Programme, therefore the information should not be used.
For the latest version of the form and further details, please see the Health and Social Care Information Centre website.For the latest version of the form and further details, please see the Health and Social Care Information Centre website.

• Part B: Cervical Screening Programme - Number of Women Invited

• Part B of KC53 requires age-banded data on the number of women invited for screening, The number invited relates to Screening Test Invitations with an APPOINTMENT DATE OFFERED between 1 April and 31 March. This date does not necessarily relate to a due date in the year - e.g. the Screening Test could be set to take place outside this period. Where a woman is invited on more than one occasion in the year, the last invitation is recorded on KC53.

  A Screening Test Invitation is an APPOINTMENT associated with an APPOINTMENT OFFER where the APPOINTMENT CLASSIFICATION CODE is National Code 06 'Screening Test'.

  A Screening Test is a CLINICAL INTERVENTION where CLINICAL INTERVENTION TYPE is National Code 28 'Screening Test'.

  Age of woman at 31 March (column 1)

• The age bands are derived from the PERSON BIRTH DATE.

  Under 20 (line 0001)
  20-24 (line 0002)
  25-29 (line 0003)
  30-34 (line 0004)
  35-39 (line 0005)
  40-44 (line 0006)
  45-49 (line 0007)
  50-54 (line 0008)
  55-59 (line 0009)
  60-64 (line 0010)
  65-69 (line 0011)
  70-74 (line 0012)
  75 & over (line 0013)

  Call (column 2)

• A count of the number of women invited for their first screen i.e. those who have never been screened before. The INVITATION TYPE of the Screening Test Invitation will have the classification First call.

  Routine recall (column 3)

• A count of the number of women invited for screening in the year as a result of a routine recall for screening. These women will have had a previous negative result and been recalled after the usual interval (3 to 5 years). The INVITATION TYPE of the Screening Test Invitation will have the classification Routine recall.

  Surveillance (column 4)

• A count of the number of women invited for early screening because of a previous abnormal screening result or following treatment for cervical abnormalities. The INVITATION TYPE of the Screening Test Invitation will have the classification Repeat in less than three years for surveillance.

  Abnormality (column 5)

• A count of the number of women invited for early screening because their last smear showed some abnormality and a repeat was advised. The INVITATION TYPE of the Screening Test Invitation will have the classification Repeat in less than three years because of abnormality.

  Inadequate smear (column 6)

• A count of the number of women invited for screening because their last smear was inadequate. The INVITATION TYPE of the Screening Test Invitation will have either the classification Repeat in less than three years because of inadequate smear, or the classification Technical recall (inadequate test).

  Target age group (line 0014)

• This counts the number of women in the Screening Programme aged between 20 and 64 on 31 March (sum of lines 0002 to 0010).

  A Screening Programme is a HEALTH PROGRAMME where the HEALTH PROGRAMME TYPE is National Code 06 'Screening Programme'.

  Total all ages (line 9999)

• This is the total for all age groups counted in lines 0001 to 0013 for each INVITATION TYPE.

KC53: Adult Screening Programmes: Cervical Screening

This return is in development by the NHS Cancer Screening Programme, therefore the information should not be used.
For the latest version of the form and further details, please see the Health and Social Care Information Centre website.For the latest version of the form and further details, please see the Health and Social Care Information Centre website.

• Part C1: Cervical Screening Programme - Number of Women Tested - by Age

• Part C1 of KC53 requires data on the women screened in the year, by invitation or opportunistically. The number screened relates to Screening Tests with a Screening Test Date between 1 April and 31 March. Where a woman is screened more than once in the year, for whatever reason, her INVITATION TYPE at her first Screening Test Date in the review period is to be recorded.

  A Screening Test is a CLINICAL INTERVENTION where the CLINICAL INTERVENTION TYPE is National Code 'Screening Test'. Screening Test Date is the same as attribute ACTIVITY DATE where ACTIVITY DATE TYPE is National Code 'Screening Test'.

  Call (column 2)

• A count of the number of women screened in the year as a result of a first call for screening within 12 months of the original invitation. These women will not have been screened before. The INVITATION TYPE of the Screening Test Invitation will have the classification First call.

  A Screening Test Invitation is an APPOINTMENT associated with an APPOINTMENT OFFER where the APPOINTMENT CLASSIFICATION CODE is National Code 'Screening Test'.

  Routine recall (column 3)

• A count of the number of women screened in the year as a result of a routine recall for screening within 12 months of the recall invitation. These women will have had a previous negative result and been recalled after the usual interval (3 to 5 years). The INVITATION TYPE of the Screening Test Invitation will have the classification Routine recall.

  Surveillance (column 4)

• A count of the number of women screened in the year as a result of a non-routine recall for screening within 12 months of the recall invitation. The INVITATION TYPE of the Screening Test Invitation will have the classification Repeat in less than 3 years for surveillance.

  Abnormality (column 5)

• A count of the number of women screened in the year as a result of a non-routine recall for screening within 12 months of the recall invitation. These women will usually have had a recent mildly abnormal smear. The INVITATION TYPE of the Screening Test Invitation will have the classification Repeat in less than 3 years because of abnormality.

  Inadequate smear (column 6)

• Enter the number of women screened in the year as a result of a technical recall within 12 months of the recall invitation. The INVITATION TYPE of the Screening Test Invitation will have either the classification Repeat in less than 3 years because of inadequate smear or the classification Technical recall (inadequate test).

  While recall suspended (column 7)

• A count of the number of women screened in the year who were suspended from the call and recall system at the time of their Screening Test Date. These women will have had a Screening Test with the OPPORTUNISTIC SCREENING TYPE classification of 'screened while recall suspended'.

  A Screening Test is a CLINICAL INTERVENTION where the CLINICAL INTERVENTION TYPE is National Code 'Screening Test'.

  While recall ceased (column 8)

• A count of the number of women screened opportunistically in the year who were ceased from the call and recall system at the time of their Screening Test Date. These women will have had a Screening Test with the OPPORTUNISTIC SCREENING TYPE classification of 'screened while recall ceased'.

  Not Invited by Programme (column 9)

• A count of the number of women screened opportunistically during the year. This includes all women whose Recall Status was "No action", "GP not informed", "GP informed", "ZZZ GP" and those women whose Recall Status was "Final non-responder" where the initial invitation was generated more than 12 months ago. These women will have had a Screening Test with the OPPORTUNISTIC SCREENING TYPE classification of 'not invited by programme'.

  Target age group (line 0014)

• This counts the number of women in the Screening Programme aged between 20 and 64 on 31 March (sum of lines 0002 to 0010).

  Total all women (line 9999)

• This is the total for all age groups counted in lines 0001 to 0013 for each INVITATION TYPE or women who have had a Screening Test with the OPPORTUNISTIC SCREENING TYPE recorded.

KC53: Adult Screening Programmes: Cervical Screening

This return is in development by the NHS Cancer Screening Programme, therefore the information should not be used.
For the latest version of the form and further details, please see the Health and Social Care Information Centre website.For the latest version of the form and further details, please see the Health and Social Care Information Centre website.

• Part C2: Cervical Screening Programme - Number of Women Tested - by Result

• Part C2 of KC53 requires data on the women aged 20 - 64 screened in the year, by invitation or opportunistically. The number screened relates to Screening Tests with a Screening Test Date between 1 April and 31 March. Where a woman is screened more than once in the year, for whatever reason, her INVITATION TYPE at her first Screening Test Date in the review period is to be recorded.

  A Screening Test is a CLINICAL INTERVENTION where the CLINICAL INTERVENTION TYPE is National Code 'Screening Test'. Screening Test Date is the same as attribute ACTIVITY DATE where the ACTIVITY DATE TYPE is National Code 'Screening Test Date'.

  Call (column 2)

• A count of the number of women screened in the year as a result of a first call for screening within 12 months of the original invitation. These women will not have been screened before. The INVITATION TYPE of the Screening Test Invitation will have the classification First call.

  A Screening Test Invitation is an APPOINTMENT associated with an APPOINTMENT OFFER where the APPOINTMENT CLASSIFICATION CODE is National Code 'Screening Test'.

  Routine recall (column 3)

• A count of the number of women screened in the year as a result of a routine recall for screening within 12 months of the recall invitation. These women will have had a previous negative result and been recalled after the usual interval (3 to 5 years). The INVITATION TYPE of the Screening Test Invitation will have the classification Routine recall.

  Surveillance (column 4)

• A count of the number of women screened in the year as a result of a non-routine recall for screening within 12 months of the recall invitation. The INVITATION TYPE of the Screening Test Invitation will have the classification Repeat in less than 3 years for surveillance.

  Abnormality (column 5)

• A count of the number of women screened in the year as a result of a non-routine recall for screening within 12 months of the recall invitation. These women will usually have had a recent mildly abnormal smear. The INVITATION TYPE of the Screening Test Invitation will have the classification Repeat in less than 3 years because of abnormality.

  Inadequate smear (column 6)

• Enter the number of women screened in the year as a result of a technical recall within 12 months of the recall invitation. The INVITATION TYPE of the Screening Test Invitation will have either the classification Repeat in less than 3 years because of inadequate smear or the classification Technical recall (inadequate test).

  While recall suspended (column 7)

• A count of the number of women screened in the year who were suspended from the call and recall system at the time of their Screening Test Date. These women will have had a Screening Test with the OPPORTUNISTIC SCREENING TYPE classification of 'screened while recall suspended'.

  A Screening Test is a CLINICAL INTERVENTION where the CLINICAL INTERVENTION TYPE is National Code 'Screening Test'.

  While recall ceased (column 8)

• A count of the number of women screened opportunistically in the year who were ceased from the call and recall system at the time of their Screening Test Date. These women will have had a Screening Test with the OPPORTUNISTIC SCREENING TYPE classification of 'screened while recall ceased'.

  Not Invited by Programme (column 9)

• A count of the number of women screened opportunistically during the year. This includes all women whose Recall Status was "No action", "GP not informed", "GP informed", "ZZZ GP" and those women whose Recall Status was "Final non-responder" where the initial invitation was generated more than 12 months ago. These women will have had a Screening Test with the OPPORTUNISTIC SCREENING TYPE classification of 'not invited by programme'.

  Result of test

• This is classified by the following CYTOLOGY RESULT TYPES:
  Inadequate (cat. 1) (line 0001)
  Negative (cat. 2) (line 0002)
  Borderline changes (cat. 8) (line 0003)
  Mild dyskaryosis (cat. 3) (line 0004)
  Moderate dyskaryosis (cat. 7) (line 0005)
  Severe dyskaryosis (cat. 4) (line 0006)
  Severe dyskaryosis/?invasive carcinoma (cat. 5) (line 0007)
  ?Glandular neoplasia (cat. 6) line 0008)

  Total women tested aged 20-64 (line 9999)

• This counts the number of women in the Screening Programme aged between 20 and 64 on 31 March (sum of lines 0001 to 0008).

  A Screening Programme is a HEALTH PROGRAMME where the HEALTH PROGRAMME TYPE is National Code 'Screening Programme'.

KC53: Adult Screening Programmes: Cervical Screening

This return is in development by the NHS Cancer Screening Programme, therefore the information should not be used.
For the latest version of the form and further details, please see the Health and Social Care Information Centre website.For the latest version of the form and further details, please see the Health and Social Care Information Centre website.

• Part C3: Cervical Screening Programme - Number of Tests - by Result

• Part C3 of KC53 requires data on all tests in the review period, not limited to the target age group 20 - 64, by invitation or opportunistically. The number screened relates to Screening Tests with a Screening Test Date between 1 April and 31 March. Where a woman is screened more than once in the year, for whatever reason, her INVITATION TYPE at her first Screening Test Date in the review period is to be recorded.

  A Screening Test is a CLINICAL INTERVENTION where the CLINICAL INTERVENTION TYPE is National Code 'Screening Test'. Screening Test Date is the same as attribute ACTIVITY DATE where the ACTIVITY DATE TYPE is National Code 'Screening Test Date'.

  Call (column 2)

• A count of the number of tests in the year as a result of a first call for screening within 12 months of the original invitation. These women will not have been screened before. The INVITATION TYPE of the Screening Test Invitation will have the classification First call.

  A Screening Test Invitation is an APPOINTMENT associated with an APPOINTMENT OFFER where the APPOINTMENT CLASSIFICATION CODE is National Code 'Screening Test'.

  Routine recall (column 3)

• A count of the number of tests in the year as a result of a routine recall for screening within 12 months of the recall invitation. These women will have had a previous negative result and been recalled after the usual interval (3 to 5 years). The INVITATION TYPE of the Screening Test Invitation will have the classification Routine recall.

  Surveillance (column 4)

• A count of the number of tests in the year as a result of a non-routine recall for screening within 12 months of the recall invitation. The INVITATION TYPE of the Screening Test Invitation will have the classification Repeat in less than 3 years for surveillance.

  Abnormality (column 5)

• A count of the number of tests in the year as a result of a non-routine recall for screening within 12 months of the recall invitation. These women will usually have had a recent mildly abnormal smear. The INVITATION TYPE of the Screening Test Invitation will have the classification Repeat in less than 3 years because of abnormality.

  Inadequate smear (column 6)

• Enter the number of tests in the year as a result of a technical recall within 12 months of the recall invitation. The INVITATION TYPE of the Screening Test Invitation will have either the classification Repeat in less than 3 years because of inadequate smear or the classification Technical recall (inadequate test).

  While recall suspended (column 7)

• A count of the number of tests in the year of women who were suspended from the call and recall system at the time of their Screening Test Date. These women will have had a Screening Test with the OPPORTUNISTIC SCREENING TYPE classification of 'Screened while recall suspended'

  A Screening Test is a CLINICAL INTERVENTION where the CLINICAL INTERVENTION TYPE is National Code 'Screening Test'.

  While recall ceased (column 8)

• A count of the number of tests in the year of women who were ceased from the call and recall system at the time of their Screening Test Date. These women will have had a Screening Test with the OPPORTUNISTIC SCREENING TYPE classification of 'screened while recall ceased'.

  Not Invited by Programme (column 9)

• A count of the number of opportunistic tests during the year. This includes all women whose Recall Status was "No action", "GP not informed", "GP informed", "ZZZ GP" and those women whose Recall Status was "Final non-responder" where the initial invitation was generated more than 12 months ago. These women will have had a Screening Test with the OPPORTUNISTIC SCREENING TYPE classification 'not invited by programme'.

  Result of test

• This is classified by the following CYTOLOGY RESULT TYPES:
  Inadequate (cat. 1) (line 0001)
  Negative (cat. 2) (line 0002)
  Borderline changes (cat. 8) (line 0003)
  Mild dyskaryosis (cat. 3) (line 0004)
  Moderate dyskaryosis (cat. 7) (line 0005)
  Severe dyskaryosis (cat. 4) (line 0006)
  Severe dyskaryosis/?invasive carcinoma (cat. 5) (line 0007)
  ?Glandular neoplasia (cat. 6) line 0008)

  Total all results (line 9999)

• This counts the number of tests in the Screening Programme for all age groups on 31 March (sum of lines 0001 to 0008).

  A Screening Programme is a HEALTH PROGRAMME where the HEALTH PROGRAMME TYPE is National Code 'Screening Programme'.

KC53: Adult Screening Programmes: Cervical Screening

This return is in development by the NHS Cancer Screening Programme, therefore the information should not be used.
For the latest version of the form and further details, please see the Health and Social Care Information Centre website.For the latest version of the form and further details, please see the Health and Social Care Information Centre website.

• Part D: Cervical Screening Programme - Result of Test

• Part D of KC53 requires age-banded data on the most severe results of cervical screening tests recorded during the year. It does not include inadequate tests. Where a woman has only one smear tested in the year which turns out to be inadequate, or more than one, all of which are inadequate, no entry is required.

• The data are based on the results of the woman's most severe test in the year and relate to Screening Tests with a Screening Test Date between 1 April - 31 March. Classifications are those of CYTOLOGY RESULT TYPES of a Request for Pathology Investigation and are in accordance with the categories shown in box 22 of HMR 101/5 Request/Report for Cervical or Vaginal Cytology.

  A Screening Test is a CLINICAL INTERVENTION where the CLINICAL INTERVENTION TYPE is National Code 'Screening Test'. Screening Test Date is the same as attribute ACTIVITY DATE where the ACTIVITY DATE TYPE is National Code 'Screening Test Date'.

  A Request for Pathology Investigation is a DIAGNOSTIC TEST REQUEST where the DIAGNOSTIC TEST REQUEST TYPE is National Code 'Request for Pathology Investigation.'

  Negative (column 2)

• A count of the number of women with a CYTOLOGY RESULT TYPE classification of Negative (cat. 2).

  Borderline (column 3)

• A count of the number of women whose most severe CYTOLOGY RESULT TYPE classification was Borderline changes (cat. 8) .

  Mild dyskaryosis (column 4)

• A count of the number of women whose most severe CYTOLOGY RESULT TYPE classification was Mild dyskaryosis (column 4) .

  Moderate dyskaryosis (column 5)

• A count of the number of women whose most severe CYTOLOGY RESULT TYPE classification was Moderate dyskaryosis (cat. 7).

  Severe dyskaryosis (column 6)

• A count of the number of women whose most severe CYTOLOGY RESULT TYPE classification was Severe dyskaryosis (cat. 4).

  Severe dyskaryosis/?invasive carcinoma (column 7)

• A count of the number of women whose most severe CYTOLOGY RESULT TYPE classification was Severe dyskaryosis/?invasive carcinoma (cat. 5).

  ?Glandular neoplasia (column 8)

• A count of the number of women whose most severe CYTOLOGY RESULT TYPE classification was ?Glandular neoplasia (cat. 6).

  Target age group (line 0014)

• This counts the number of women in the Screening Programme aged between 20 and 64 on 31 March (sum of lines 0002 to 0010).

  A Screening Programme is a HEALTH PROGRAMME where the HEALTH PROGRAMME TYPE is National Code 'Screening Programme'.

  Total all ages (line 9999)

• This is the total for all age groups counted in lines 0001 to 0013 for each CYTOLOGY RESULT TYPE classification.

KC53: Adult Screening Programmes: Cervical Screening

This return is in development by the NHS Cancer Screening Programme, therefore the information should not be used.
For the latest version of the form and further details, please see the Health and Social Care Information Centre website.For the latest version of the form and further details, please see the Health and Social Care Information Centre website.

• Part E: Cervical Screening Programme - Notification of Result - Waiting Times

• This part of the return requires information on the length of time elapsing between a woman taking a smear test and when notification of the result is sent to her by the call and recall service. The national standard to be achieved is that women should be advised in writing of the result of their test four weeks from the date the test was taken. The information is used to monitor the performance of Screening Programmes and laboratories.

  A Screening Programme is a HEALTH PROGRAMME where the HEALTH PROGRAMME TYPE is National Code 'Screening Programme'.

• The return also collects information on those instances where the letter is sent directly by the laboratory or by some other agency instead of by the call and recall service.

• The return counts all tests and not just those tests with the most severe result. It includes only smears taken as part of a NHS Screening Programme.

  Number of weeks between date smear is taken and date result is sent from the call and recall service

• This is the number of weeks between the Screening Test Date and the Screening Result Sent Date of the Screening Test, where the RESULT SENT DIRECT indicator is Yes.

  A Screening Test is a CLINICAL INTERVENTION where the CLINICAL INTERVENTION TYPE is National Code 'Screening Test'. Screening Test Date is the same as attribute ACTIVITY DATE where the ACTIVITY DATE TYPE is National Code 'Screening Test Date'. Screening Result Sent Date is the same as attribute ACTIVITY DATE where ACTIVITY DATE TYPE is National Code 'Screening Result Sent Date'.

• They are sub-divided into the following time periods:

  Less than or equal to four weeks (line 0001)
  > 4 weeks up to 6 weeks (line 0002)
  > 6 weeks up to 8 weeks (line 0003)
  > 8 weeks up to 10 weeks (line 0004)
  > 10 weeks up to 12 weeks (line 0005)
  > Over 12 weeks (line 0006)

  Number of tests (column 2)

• This counts the number of Screening Tests where results were sent from the call and recall service for each time period.

  Total (line 0007)

• This is the total of Screening Tests for all time periods counted in lines 0001 to 0006.

  Letter not sent by the call and recall service (line 0008)

• This counts the number of Screening Tests where the RESULT SENT DIRECT indicator is No, indicating that the result was not sent by the call and recall service.

KC61: Pathology Laboratories - Cervical Cytology and Outcome of Gynaecological Referrals

This return is in development by the NHS Cancer Screening Programme, therefore the information should not be used.
For the latest version of the form and further details, please see the Health and Social Care Information Centre website.For the latest version of the form and further details, please see the Health and Social Care Information Centre website.

• Contextual Overview

• The Department of Health, NHS Cervical Screening Programme (NHSCSP), Strategic Health Authorities and trusts require information from Pathology Laboratories on cervical cytology and outcome of referrals.
  
  A Pathology Laboratory is a LABORATORY where the LABORATORY TYPE is National Code 01 'Pathology Laboratory'.

• The information helps to monitor the process of achieving the Government's target to reduce the incidence of invasive cervical cancer and to ensure that the screening programme is managed effectively. The information is used to ensure that the laboratory is achieving acceptable standards in examining smears in line with guidance provided by the NHS Cervical Screening Programme.

• Information on the return is also used in Public Expenditure Survey (PES) negotiations, resource allocation to the NHS and Departmental accountability.

• Information based on the KC61 return is published annually by the Department in the Statistical Bulletin `Cervical Screening Programme'.

  Completing Return KC61: Pathology Laboratories - Cervical Cytology and Outcome of Referrals

• KC61 returns are required by all Pathology Laboratories carrying out cervical cytology within NHS Health Care Providers. This applies to independently managed NHS laboratories, including cytopathology laboratories and also private laboratories if they are commissioned to report on smears for the NHS.

  Each return requires the ORGANISATION CODE and ORGANISATION NAME of the NHS Trust and must be signed by a CONSULTANT in one of the Pathology MAIN SPECIALTY CODES. It also requires the pathology LABORATORY NAME and pathology LABORATORY CODE. Note that pathology LABORATORY CODES are maintained and issued by the Organisation Data Service on behalf of the NHS Cervical Screening Programme.

  For the Organisation Data Service contact details, see Contact Details.

• A Pathology Laboratory's KC61 return should include all the original Requests for Pathology Investigation received by that laboratory. A Request for Pathology Investigation forwarded to another laboratory should only be included in the first laboratory's return (except Part A3).
  
  A Request for Pathology Investigation is a DIAGNOSTIC TEST REQUEST where the DIAGNOSTIC TEST REQUEST is National Code 03 'Request for Pathology Investigation'.

• Smears re-screened within the same Laboratory as part of internal or external quality control or for any other reason should not be included in the KC61 return. The number of requests sent to or received from another Laboratory for primary screening or other reason should be recorded in Part A3.

• Where more than one slide is associated with one Request for Pathology Investigation, only the most significant CYTOLOGY RESULT TYPES may be counted for the KC61.

• The return KC61 is completed annually and submitted within two months of the end of the period.

• Parts A and B of the return relate to all smears reported by the laboratory where the smear was received and registered between 1 April of one year and 31 March of the following year. If this date is not recorded, the CERVICAL SMEAR EXAMINED DATE can be used as a proxy. Part C1 of the return relates to smears where the date of the smear which led to a referral fell in the first three months of the financial year (April, May and June). Part C2 is a duplicate of Part C1, but will collect data relating to gynaecological referrals from smears registered during the whole of the financial year prior to the current year.

KC61: Pathology Laboratories - Cervical Cytology and Outcome of Gynaecological Referrals

This return is in development by the NHS Cancer Screening Programme, therefore the information should not be used.
For the latest version of the form and further details, please see the Health and Social Care Information Centre website.For the latest version of the form and further details, please see the Health and Social Care Information Centre website.

• Part A1: Number of Smears Examined by Source of Smear

• Part A1 requires data on the number of results recorded analysed by SMEAR SOURCE TYPE and CYTOLOGY RESULT TYPES and are in accordance with the categories shown in boxes 9 and 22 of HMR 101/5 Request/Report for Cervical or Vaginal Cytology.

• Column 10 counts the total of cytology samples examined. These are subdivided by the test results, derived from the CYTOLOGY RESULT TYPE classifications (columns 2 - 9).

• The totals are further subdivided by SMEAR SOURCE TYPE (lines 0001-0006).

• Line 0007 of the return counts the combined total smears in lines 0001 and 0002 i.e. total smears examined from SMEAR SOURCE TYPE classifications of 'GENERAL MEDICAL PRACTITIONER' and 'NHS Community Clinic - this includes Sexual and Reproductive Health Clinics, well women clinics and young persons' clinics, other than those run by GENERAL MEDICAL PRACTITIONERS'.

• Line 008 of the return counts the Grand Total of lines 0001 to 0006 for columns 2 to 10.

KC61: Pathology Laboratories - Cervical Cytology and Outcome of Gynaecological Referrals

This return is in development by the NHS Cancer Screening Programme, therefore the information should not be used.
For the latest version of the form and further details, please see the Health and Social Care Information Centre website.For the latest version of the form and further details, please see the Health and Social Care Information Centre website.

• Part A2: Laboratory Processing from Receipt of Smear to Authorisation of Report

• Part A2 collects information about the backlog of smears in laboratories. The laboratory which receives the original request should issue the report and include the information within this return.

  Total number of smears registered

• This is the total number of Pathology Laboratory Investigations received and registered in:

  Quarter 1 - As at 30 June yyyy (Line 0001)

  Quarter 2 - As at 30 September yyyy (Line 0002)

  Quarter 3 - As at 31 December yyyy (Line 0003)

  Quarter 4 - As at 31 March yyyy (Line 0004)

  
  A Pathology Laboratory Investigation is a CLINICAL INTERVENTION where CLINICAL INTERVENTION TYPE is National Code 24 'Pathology Laboratory Investigation'.

  Number of results reported (to woman or PCT) within

• The number of results reported are subdivided into the following time periods:

  0-2 weeks 0-14 days (column 3)

  3-4 weeks 15-28 days (column 4)

  5-6 weeks 29-42 days (column 5)

  7-8 weeks 43-56 days (column 6)

  9-10 weeks 57-70 days (column 7)

  More than 10 weeks over 70 days (column 8)

• The interval to be reported is from the date of receipt of the smear at the laboratory, the SAMPLE RECEIPT DATE, and the date of authorisation of the final report, the PATHOLOGY RESULT REPORTED DATE (for the SAMPLE collected).

  Total (line 0005)

• This is the total for all time periods counted in lines 0001 to 0004.

  Part A3: Requests Screened for/by Another Laboratory

• Part A3 records information about which laboratories import and export smears.

  Requests Sent To Another Laboratory For Screening (Line 0001)

• This requires the number of Requests for Pathology Investigation where the DIAGNOSTIC TEST REQUEST for the screening is to be sent to and carried out by another Pathology Laboratory, sub-divided by details of Laboratory sent to and whether for primary screening or 'other'. 'Other' may include rapid review, checking, abnormal or clinical reporting etc.
  
  A Pathology Laboratory is a LABORATORY where the LABORATORY TYPE is National Code 01 'Pathology Laboratory'. A Request for Pathology Investigation is a DIAGNOSTIC TEST REQUEST where the DIAGNOSTIC TEST REQUEST is National Code 03 'Request for Pathology Investigation'.

  Requests Received From Another Laboratory For Screening (Line 0002)

• This requires the number of Requests for Pathology Investigation where the DIAGNOSTIC TEST REQUEST for the screening of the received smear has been sent from another Pathology Laboratory, sub-divided by details of Laboratory received from and whether for primary screening or 'other'. 'Other' may include rapid review, checking, abnormal or clinical reporting etc.

  Part A3: Where More Than One Smear is Taken

• Part A3 also requires the number of instances where a single report is derived from more than one sample.

  Number of Instances Where a Single Report is Derived from More Than One Sample (Line 0003)

• This requires the number of Requests for Pathology Investigation where there is more than one SAMPLE collected. Full details should be available on request.

KC61: Pathology Laboratories - Cervical Cytology and Outcome of Gynaecological Referrals

This return is in development by the NHS Cancer Screening Programme, therefore the information should not be used.
For the latest version of the form and further details, please see the Health and Social Care Information Centre website.For the latest version of the form and further details, please see the Health and Social Care Information Centre website.

• Part B: Results of Smears from GP and NHS Community Clinics Only by Age Group of Women

• Part B requires the results of smears examined, but only those where the SMEAR SOURCE TYPE is classified as either 'GENERAL MEDICAL PRACTITIONER' or 'NHS Community Clinic - this includes Sexual and Reproductive Health Clinics, well women clinics and young persons' clinics, other than those run by GENERAL MEDICAL PRACTITIONERS'.

• Columns 2 - 9 count the number of samples examined for each CYTOLOGY RESULT TYPES and are in accordance with the categories shown in box 22 of HMR 101/5 Request/Report for Cervical or Vaginal Cytology.

• These results are further broken down into age bands derived from the PERSON BIRTH DATE of the PERSON - the woman from whom the cervical smear was taken. This is the age of the woman at the date of the smear and not the woman's age on 31 March. The smears are the subject of the Request for Pathology Investigation.
  
  A Request for Pathology Investigation is a DIAGNOSTIC TEST REQUEST where the DIAGNOSTIC TEST REQUEST is National Code 03 'Request for Pathology Investigation'.

  Total 20 - 64 (line 0014)

• This counts the number of women in NHS Cervical Screening Programme aged between 20 and 64 on 31 March (sum of lines 0002 to 0010).

  Grand Total (line 0015)

• This is the total for all age groups examined in lines 0001 to 0013. This total should be the same as line 0007 in Part A1.

KC61: Pathology Laboratories - Cervical Cytology and Outcome of Gynaecological Referrals

This return is in development by the NHS Cancer Screening Programme, therefore the information should not be used.
For the latest version of the form and further details, please see the Health and Social Care Information Centre website.For the latest version of the form and further details, please see the Health and Social Care Information Centre website.

• Part C1: Outcome by 31 March yyyy for Women Recommended for Gynaecological Referral where the Smear was Registered during April- June yyyy.

• Part C1 requires the analysis of the number of women subsequently referred for gynaecological investigation following a smear. This is where the CYTOLOGY SCREENING ACTION TYPE of a Screening Test has a classification of Refer for medical assessment or under medical treatment (Suspend) (S). The date of the smear must be between 1 April and 30 June of the current data year. The CYTOLOGY RESULT TYPES for each woman is used to allocate her to one of appropriate subdivisions of Most significant result in columns 3 to 9.
  
  A Screening Test is a CLINICAL INTERVENTION where CLINICAL INTERVENTION TYPE is National Code 28 'Screening Test'.

• Note that CYTOLOGY RESULT TYPE classifications of Severe dyskaryosis (cat. 4), Severe dyskaryosis/invasive carcinom a (Cat. 5) and Glandular neoplasia (Cat. 6) are recorded separately in columns 7,8 and 9 respectively.

• CYTOLOGY RESULT TYPE with a classification of Negative (cat. 2) are not counted.

• The number of Most significant results in the CYTOLOGY RESULT TYPE columns (columns 3 - 9) are further analysed by the BIOPSY REFERRAL OUTCOME (lines 0001-0014). For cervical histology, biopsies are taken at colposcopy.

• Note that Cervical cancer is sub-divided into 'stage 1B or worse' (line 0001) and 'stage 1A' (line 0002) and that there are four options to describe results which are not applicable or not known: 'Seen in Colposcopy - NAD no biopsy taken' (line 0009), 'Outcome known - none of the above' (line 0010), 'Seen in Colposcopy - result not known' (line 0011) and 'No outcome available' (line 0012).

• Part C1 also includes the formula to calculate the Positive Predictive Value (PPV) of smears reported as moderate dyskaryosis or worse to enable the laboratory to assess whether or not they are reaching an achievable standard.

• Part C1 includes the formula to calculate Lost to follow-up of smears reported as 'Seen in colposcopy - result not known' (line 0011) and 'No outcome available' (line 0012), as a percentage of the Total.

• Provision has been made to record details of non-cervical cancers at the bottom of Part C1.

KC61: Pathology Laboratories - Cervical Cytology and Outcome of Gynaecological Referrals

This return is in development by the NHS Cancer Screening Programme, therefore the information should not be used.
For the latest version of the form and further details, please see the Health and Social Care Information Centre website.For the latest version of the form and further details, please see the Health and Social Care Information Centre website.

• Part C2: Retrospective Collection

  Outcome by 31 March yyyy for Women Recommended for Gynaecological Referral where the Smear was Registered during April yyyy - March yyyy.

• Part C2 is a duplicate of Part C1 but will collect data relating to gynaecological referrals from smears registered during the whole of the financial year prior to the current year. This is where the CYTOLOGY SCREENING ACTION TYPE of a Screening Test has a classification of Refer for medical assessment or under medical treatment (Suspend) (S). The date of the smear must be between 1 April and 31 March of the previous data year. The CYTOLOGY RESULT TYPES for each woman is used to allocate her to one of appropriate subdivisions of Most significant result in columns 3 to 9.
  
  A Screening Test is a CLINICAL INTERVENTION where CLINICAL INTERVENTION TYPE is National Code 28 'Screening Test'.

• Note that CYTOLOGY RESULT TYPE classifications of 'Severe dyskaryosis (cat. 4)', 'Severe dyskaryosis/invasive carcinom a (Cat. 5)' and 'Glandular neoplasia (Cat. 6)' are recorded separately in columns 7,8 and 9 respectively.

• CYTOLOGY RESULT TYPES with a classification of 'Negative (cat. 2)' are not counted.

• The number of Most significant results in the CYTOLOGY RESULT TYPE columns (columns 3 - 9) are further analysed by the BIOPSY REFERRAL OUTCOME (lines 0001-0014). For cervical histology, biopsies are taken at colposcopy.

• Note that Cervical cancer is sub-divided into 'stage 1B or worse' (line 0001) and 'stage 1A' (line 0002) and that there are four options to describe results which are not applicable or not known: 'Seen in Colposcopy - NAD no biopsy taken' (line 0009), 'Outcome known - none of the above' (line 0010), 'Seen in Colposcopy - result not known' (line 0011) and 'No outcome available' (line 0012).

• Part C2 also includes the formula to calculate the Positive Predictive Value (PPV) of smears reported as moderate dyskaryosis or worse to enable the laboratory to assess whether or not they are reaching an achievable standard.

• Part C2 includes the formula to calculate Lost to follow-up of smears reported as 'Seen in colposcopy - result not known' (line 0011) and 'No outcome available' (line 0012), as a percentage of the Total.

• Provision has been made to record details of non-cervical cancers at the bottom of Part C2.

KC65: Colposcopy Clinics, Referrals, Treatments and Outcomes

This return is in development by the NHS Cancer Screening Programme, therefore the information should not be used.
For the latest version of the form and further details, please see the Health and Social Care Information Centre website.For the latest version of the form and further details, please see the Health and Social Care Information Centre website.

• Contextual Overview

• The Department of Health, NHS Cervical Screening Programme (NHSCSP) and Regional Offices require information from NHS Health Care Providers on colposcopy clinic activity.

• The KC65 forms part of the wider NHS Cancer Information Strategy which aims to improve the effectiveness and efficiency of care delivery for those with actual or suspected cancer, throughout the PATIENT journey.

• The information is used to monitor the process of achieving the Government's target to reduce the incidence of invasive cervical cancer and to monitor the performance of colposcopy clinics on local, regional and national levels.

• Information on the return is also used in Public Expenditure Survey (PES) negotiations, resource allocation to the NHS and Departmental accountability.

• Information based on the KC65 return is published annually by the Department in the Statistical Bulletin Cervical Screening Programme.

  Completing Return KC65 - Colposcopy Clinics: Referrals, Treatments and Outcomes

• KC65 is a quarterly return with the first quarter starting on 1 April and the last quarter ending on 31 March. Returns must be submitted by the thirtieth working day after the end of the quarter.

• The KC65 return requires the ORGANISATION CODE and ORGANISATION NAME of the NHS Health Care Provider - NHS Trust or Primary Care Trust - as well as the name of a contact and the contact telephone number on the front page. It must be signed and dated by the person completing the return.

• The British Society for Colposcopy and Cervical Pathology has agreed a Minimum Data Set (MDS) for colposcopy services, currently being introduced into Colposcopy Clinics. The MDS meets professional requirements for audit and quality improvement as well as departmental needs, and provides the information needed to complete the KC65.

  Colposcopy

• Colposcopy is a Patient Procedure carried out on a woman who has been referred to a Colposcopy Clinic following a Screening Test carried out either as part of a Screening Programme or opportunistically. Alternatively the woman may be referred as a result of clinical indications.

  A Screening Programme is a HEALTH PROGRAMME where the HEALTH PROGRAMME TYPE is National Code 06 'Screening Programme'.

  Patient Procedure and Screening Test are both a CLINICAL INTERVENTION where CLINICAL INTERVENTION TYPE is National Code 25 'Patient Procedure' and 28 'Screening Test' respectively.

KC65 - Colposcopy Clinics: Referrals, Treatments and Outcomes

This return is in development by the NHS Cancer Screening Programme, therefore the information should not be used.
For the latest version of the form and further details, please see the Health and Social Care Information Centre website.For the latest version of the form and further details, please see the Health and Social Care Information Centre website.

• Part A - Women referred to colposcopy by result of referral smear and time from referral to first appointment

• Part A of the KC65 return is a count of the number of women referred for colposcopy. This information is used to monitor referral patterns to ensure that guidelines on referral are being followed.

• A colposcopy is a Patient Procedure carried out during a Clinic Attendance Consultant or Clinic Attendance Nurse. The PATIENT will have been referred to the Colposcopy Clinic:

  -	following a Screening Test carried out either as part of a Screening Programme or opportunistically.
  or
  -	as a result of clinical indication

  A Screening Programme is a HEALTH PROGRAMME where the HEALTH PROGRAMME TYPE is National Code 06 'Screening Programme'.

  Patient Procedure and Screening Test are both a CLINICAL INTERVENTION where CLINICAL INTERVENTION TYPE is National Code 25 'Patient Procedure' and 28 'Screening Test' respectively.

  Clinic Attendance Consultant and Clinic Attendance Nurse are both a CARE CONTACT where CARE CONTACT TYPE is National Code 06 'Clinic Attendance Consultant' and 10 'Clinic Attendance Nurse' respectively.

  In cases where there is both a clinical indication and a Screening Test referral smear, the referral should be treated as clinical indication.

• The data is based on the woman's first Out-Patient Appointment in the quarter regardless of whether she attended the clinic or not.

  An Out-Patient Appointment is an APPOINTMENT.

  Time from referral to first appointment (lines 0001 to 0005)

• Lines 0001 to 0005 are counts of REFERRAL REQUESTS by the time from referral to first appointment. This should be measured from the PATHOLOGY RESULT REPORTED DATE for referrals following a screening test, and from the SERVICE REQUEST DATE for all other REFERRAL REQUESTS, to the APPOINTMENT DATE of the first Out-Patient Appointment.

  For PATIENTS with a first APPOINTMENT which was cancelled by the clinic (ATTENDED OR DID NOT ATTEND was National Code 4 'Appointment cancelled or postponed by the Health Care Provider'), the time is measured from referral to the subsequent first APPOINTMENT.

  Referral Indication - Result of referral smear (columns 2 to 8)

• These columns count all the women with a REFERRAL REQUEST for colposcopy with a COLPOSCOPY REFERRAL INDICATION classification of 'Screening smear'. These are persons in a Screening Programme who have been given a Screening Test as part of a planned Screening Programme. It also includes women screened opportunistically, these women have had a Screening Test with the OPPORTUNISTIC SCREENING TYPE recorded.

  In addition, if a person in a Screening Programme has been suspended from the Screening Programme following colposcopy and is currently having surveillance smears as indicated by the OPPORTUNISTIC SCREENING TYPE classification of 'Screened while recall suspended', it may be that an abnormal smear will cause the woman to be re-referred to colposcopy. In this case the COLPOSCOPY REFERRAL INDICATION classification should be 'Screening smear', regardless of whether or not she has been discharged from colposcopy at this time.

• The information in columns 2-8 is based on the cervical screening test results, which led to the REFERRAL REQUEST. Classifications are those of CYTOLOGY RESULT TYPES of a Request for Pathology Investigation and are in accordance with the categories shown in box 22 of HMR 101/5 Request/Report for Cervical or Vaginal Cytology.

  Where the cervical screening test results which led to the REFERRAL REQUEST indicates more than one result type, the most severe result should recorded as the CYTOLOGY RESULT TYPE.

  A Request for Pathology Investigation is a DIAGNOSTIC TEST REQUEST where the DIAGNOSTIC TEST REQUEST TYPE is National Code 03 'Request for Pathology Investigation'.

  Inadequate (column 2)

• A count of the number of women with a CYTOLOGY RESULT TYPE classification of 'Inadequate sample (cat.1)'.

  NHS Cervical Screening Programme guidelines state the recording of three cervical screening tests with a CYTOLOGY RESULT TYPE classification of 'Inadequate sample (cat.1)' indicates referral to colposcopy however, referral to colposcopy may occur following an inadequate smear for other reasons.

  Borderline changes (column 3)

• A count of the number of women with a CYTOLOGY RESULT TYPE classification of 'Borderline changes (cat.8)'.

  NHS Cervical Screening Programme guidelines state the recording of three cervical screening tests with a CYTOLOGY RESULT TYPE classification of 'Borderline changes (cat.8)' indicates referral to colposcopy however, referral to colposcopy may occur following a borderline smear for other reasons.

  Mild dyskaryosis (column 4)

• A count of the number of women with a CYTOLOGY RESULT TYPE classification of 'Mild dyskaryosis (cat.3)'.

  Moderate dyskaryosis (column 5)

• A count of the number of women with a CYTOLOGY RESULT TYPE classification of 'Moderate dyskaryosis (cat. 7), including abnormal, unclassifiable and ungraded smears'.

  Severe dyskaryosis (column 6)

• A count of the number of women with a CYTOLOGY RESULT TYPE classification of 'Severe dyskaryosis (cat.4)'.

  Severe dyskaryosis/invasive carcinoma (column 7)

• A count of the number of women with a CYTOLOGY RESULT TYPE classification of 'Severe dyskaryosis/?invasive carcinoma (cat.5)'.

  Glandular neoplasia (column 8)

• A count of the number of women with a CYTOLOGY RESULT TYPE classification of '?Glandular neoplasia (cat.6), including adenocarcinoma'.

  Referral Indication - Clinical indication (columns 9, 10)

• These columns count women with a REFERRAL REQUEST for colposcopy with a COLPOSCOPY REFERRAL INDICATION classification of 'Clinical indication'.

  Where a woman is referred with symptoms and is given a Screening Test the COLPOSCOPY REFERRAL INDICATION should still be a classification of 'Clinical indication' and not 'Screening smear'. Where no symptoms are present the COLPOSCOPY REFERRAL INDICATION should not be a classification of 'Clinical indication'.

  A Screening Test is a CLINICAL INTERVENTION where CLINICAL INTERVENTION TYPE is National Code 28 'Screening Test'.

  Clinical Indication Urgent (column 9)

• A count of the number of women with a COLPOSCOPY REFERRAL INDICATION classification of 'urgent'. This is restricted to cervical lesions suspicious of cancer, or post-coital bleeding of over four weeks where the patient is aged over 35.

  Clinical Indication Non-Urgent (column 10)

• A count of the number of women with a COLPOSCOPY REFERRAL INDICATION classification of 'non-urgent'. This includes all other symptomatic referrals for colposcopy.

  Other (column 11)

• A count of the number of women with a CYTOLOGY RESULT TYPE classification of 'Other' or with no CYTOLOGY RESULT TYPE and no COLPOSCOPY REFERRAL INDICATION.

  Entries for a CYTOLOGY RESULT TYPE classification of 'Other' should only occur in exceptional circumstances. NHS Cervical Screening Programme (NHSCSP) guidelines state that all smears should be identified as belonging to one of the eight recognised category classifications of CYTOLOGY RESULT TYPE. 'Other' does not correspond to these recognised categories and should be used to record those rare cases in which a recognised category is not appropriate.

  Otherwise this column should only be used in the rare situations where usual categorisation is not appropriate. Examples include women with incomplete or missing records and women who have moved from abroad.

  Where an entry is present in column 11 supporting notes should be recorded in the available box on the first page of the KC65 form.

  Total number referred (column 12)

• This is the total of women referred for colposcopy, broken down by time from referral to first appointment

  Total (line 0006)

• This is the total for all women counted in columns 2 to 12.

KC65 - Colposcopy Clinics: Referrals, Treatments and Outcomes

This return is in development by the NHS Cancer Screening Programme, therefore the information should not be used.
For the latest version of the form and further details, please see the Health and Social Care Information Centre website.For the latest version of the form and further details, please see the Health and Social Care Information Centre website.

• Part B - Appointments for Colposcopy

• Part B of the KC65 return is a breakdown of appointments by cancellation/non-attendance, and type of appointment. This information will allow monitoring of non-attendances, patient cancellations, and clinic cancellations.

  It includes all Out-Patient Appointments with an APPOINTMENT DATE within the REPORTING PERIOD.

  An Out-Patient Appointment is an APPOINTMENT.

  Attendance Status

• The Attendance status is derived from the value of ATTENDED OR DID NOT ATTEND for the Out-Patient Appointment.

  Attended (line 0001)

• The number of appointments for which ATTENDED OR DID NOT ATTEND was either National Code 5 'attended on time or, if late, before the relevant care professional was ready to see the patient', or National Code 6 'arrived late, after the relevant care professional was ready to see the patient, but was seen'.

  Cancelled by patient - in advance (line 0002)

• The number of appointments for which ATTENDED OR DID NOT ATTEND was National Code 2 'appointment cancelled by, or on behalf of, the patient' - before the appointment date.

  Cancelled by patient - on the day (line 0003)

• The number of appointments for which ATTENDED OR DID NOT ATTEND was National Code 2 'appointment cancelled by, or on behalf of, the patient' - on the appointment day.

  Cancelled by Clinic (line 0004)

• The number of appointments for which ATTENDED OR DID NOT ATTEND was National Code 4 'appointment cancelled or postponed by the Health Care Provider'.

  DNA - no advance warning (line 0005)

• The number of appointments for which ATTENDED OR DID NOT ATTEND was National Code 3 'did not attend - no advance warning given'.

  DNA - arrived late (line 0006)

• The number of appointments for which ATTENDED OR DID NOT ATTEND was National Code 7 'patient arrived late and could not be seen'.

  DNA - left without being seen (line 0007)

• The number of appointments for which ATTENDED OR DID NOT ATTEND was national Code 3 'did not attend - no advance warning given' (arrived, but did not wait to be seen).

  Total (line 0008)

• This is the total of all women counted in lines 0001 to 0007.

  Appointment Type

• Columns 2 to 4 require counts of colposcopy Out-Patient Appointments by APPOINTMENT TYPE.

  An Out-Patient Appointment is an APPOINTMENT.

  New (column 2)

• The number of colposcopy Out-Patient Appointments which are first APPOINTMENTS.

  Return for Treatment (column 3)

• The number of colposcopy Out-Patient Appointments where the APPOINTMENT TYPE is National Code 01 'Treatment: An appointment specifically for treatment'.

  Follow Up (column 4)

• The number of colposcopy Out-Patient Appointments which are follow-up APPOINTMENTS where the APPOINTMENT TYPE is National Code 02 'Surveillance: All other appointments'.

  Total (column 5)

• This is the total for all women in columns 3 to 5.

KC65 - Colposcopy Clinics: Referrals, Treatments and Outcomes

This return is in development by the NHS Cancer Screening Programme, therefore the information should not be used.
For the latest version of the form and further details, please see the Health and Social Care Information Centre website.For the latest version of the form and further details, please see the Health and Social Care Information Centre website.

• Part C1 - First attendances by type of procedure and result of referral

• Parts C1 and C2 of the KC65 return are counts of procedures undertaken at colposcopy clinics, showing the nature of treatment by result of referral. The information is used to monitor treatment patterns to ensure that treatment guidelines, such as on the number of biopsies taken, are met.

• Parts C1 and C2 are identical, except that Part C1 relates to initial treatment at first attendance, and Part C2 relates to all attendances. For part C1 data is collected on the woman's first Clinic Attendance Consultant or Clinic Attendance Nurse in the REPORTING PERIOD.

  Where a woman has a smear taken during the attendance the COLPOSCOPY PRIME PROCEDURE TYPE should be recorded as classification 'No treatment; no treatment received and no biopsy taken'.

  Clinic Attendance Consultant and Clinic Attendance Nurse are both a CARE CONTACT where CARE CONTACT TYPE is National Code 06 'Clinic Attendance Consultant' and 10 'Clinic Attendance Nurse' respectively.

  For Clinic Attendance Consultant and Clinic Attendance Nurse, a first attendance is the first in a series of the only attendance at the clinic by a patient.

• The procedures undertaken in the colposcopy clinics are Patient Procedure. Only one Patient Procedure should be counted for each woman's first attendance. If more than one procedure is carried out, the most severe should be recorded for KC65.

  Patient Procedure is a CLINICAL INTERVENTION where CLINICAL INTERVENTION TYPE is National Code 25 'Patient Procedure'.

  Result of referral smear

• Lines 0001 to 0008 require data on the number of women referred for colposcopy by CYTOLOGY RESULT TYPES.

  Inadequate (line 0001)

• A count of the number of women with a CYTOLOGY RESULT TYPE classification of 'Inadequate sample (cat. 1)'.

  Borderline changes (line 0002)

• A count of the number of women with a CYTOLOGY RESULT TYPE classification of 'Borderline changes (cat. 8)'.

  Mild dyskaryosis (line 0003)

• A count of the number of women with a CYTOLOGY RESULT TYPE classification of 'Mild dyskaryosis (cat. 3)'.

  Moderate dyskaryosis (line 0004)

• A count of the number of women with a CYTOLOGY RESULT TYPE classification of 'Moderate dyskaryosis (cat. 7), including abnormal, unclassifiable and ungraded smears'.

  Severe dyskaryosis (line 0005)

• A count of the number of women with a CYTOLOGY RESULT TYPE classification of 'Severe dyskaryosis (cat. 4)'.

  Severe dyskaryosis/invasive carcinoma (line 0006)

• A count of the number of women with a CYTOLOGY RESULT TYPE classification of 'Severe dyskaryosis/invasive carcinoma (cat. 5)'.

  Glandular neoplasia (line 0007)

• A count of the number of women with a CYTOLOGY RESULT TYPE classification of 'Glandular neoplasia (cat. 6), including adenocarcinoma'.

  Referral Indication - Clinical indication (lines 0008, 0009)

• These columns count first attendances for women with a REFERRAL REQUEST for colposcopy with a COLPOSCOPY REFERRAL INDICATION classification of 'Clinical indication'.

  Note all procedures carried out on women who have been referred to the colposcopy clinic with a REFERRAL REQUEST with a COLPOSCOPY REFERRAL INDICATION of classification Clinical indication should be recorded in this line regardless of the result of any smear taken after the referral.

  Clinical Indication Urgent (line 0008)

• A count of the number of women with a COLPOSCOPY REFERRAL INDICATION of classification of 'urgent'. This is restricted to cervical lesions suspicious of cancer, or post-coital bleeding of over four weeks where the patient is aged over 35.

  Clinical Indication Non-Urgent (line 0009)

• A count of the number of women with a COLPOSCOPY REFERRAL INDICATION classification of 'non-urgent'. This includes all other symptomatic referrals for colposcopy

  Other (line 0010)

• A count of the number of women with a COLPOSCOPY REFERRAL INDICATION classification of 'Other'.

  Entries recorded in Other (line 0010) should only occur in exceptional circumstances. NHS Cervical Screening Programme (NHSCSP) guidelines state that all smears should be identified as belonging to one of the eight recognised category classifications of CYTOLOGY RESULT TYPE. Other (line 0010) does not correspond to these recognised categories and should be used to record those rare cases in which a recognised category is not appropriate. Where an entry is present in Other (line 0010) then supporting notes should be recorded in the available box on the first page of the KC65 form.

  Total (line 0011)

• This is the total for all women counted in columns 2 to 8.

  No treatment (column 2)

• This counts the number of women who received no treatment and for whom was recorded a COLPOSCOPY PRIME PROCEDURE TYPE classification of 'No treatment; no treatment received and no biopsy taken'.

  Procedure Type

  Diagnostic biopsy (punch) (column 3)

• This counts the number of women who received no treatment and for whom a COLPOSCOPY PRIME PROCEDURE TYPE classification of 'Diagnostic biopsy (punch); no treatment received and biopsy type recorded as directed biopsy or multiple directed biopsy, or any other biopsy taken for diagnostic purposes only' was recorded.

  Treatment biopsy or treatment/diagnostic biopsy - Excision (column 4)

• This counts the number of women who for whom was recorded a COLPOSCOPY PRIME PROCEDURE TYPE classification of 'Loop/laser excision or knife cone; treatment method recorded as loop/laser excision or knife cone and biopsy type recorded as other than no biopsy. This will include LLETZ and NEEP'.

  Ablation + No Biopsy taken or biopsy result not yet known (column 5)

• This counts the number of women who for whom was recorded a COLPOSCOPY PRIME PROCEDURE TYPE classification of 'Ablation; treatment method recorded as ablation. This will include cold coagulation, Cryotherapy, cautery and diathermy. (ii) no biopsy taken, or biopsy result not known by clinic'.

  Ablation + Biopsy (column 6)

• This counts the number of women for whom COLPOSCOPY PRIME PROCEDURE TYPE classification of 'Ablation; treatment method recorded as ablation. This will include cold coagulation, Cryotherapy , cautery and diathermy. (i) biopsy result available' was recorded.

  Other (column 7)

• This counts the number of women for whom COLPOSCOPY PRIME PROCEDURE TYPE classification of 'Other; treatment method recorded as other and biopsy type recorded as other than no biopsy . This will include polyp avulsion and treatment with silver nitrate' was recorded. It excludes any treatment that is not related to cervical abnormalities.

  Number of first attendances (column 8)

• This is the total of all first attendances (see paragraph 2), subdivided by the CYTOLOGY RESULT TYPE classifications.

KC65 - Colposcopy Clinics: Referrals, Treatments and Outcomes

This return is in development by the NHS Cancer Screening Programme, therefore the information should not be used.
For the latest version of the form and further details, please see the Health and Social Care Information Centre website.For the latest version of the form and further details, please see the Health and Social Care Information Centre website.

• Part C2 - All attendances by type of procedure and result of referral

• Parts C1 and C2 of the KC65 return are counts of procedures undertaken at colposcopy clinics, showing the nature of treatment by result of referral. The information is used to monitor treatment patterns to ensure that treatment guidelines, such as on the number of biopsies taken, are met.

• Parts C1 and C2 are identical, except that Part C1 relates to initial treatment at first attendance, and Part C2 relates to all attendances. For part C2 data is collected on each Clinic Attendance Consultant or Clinic Attendance Nurse in the REPORTING PERIOD.

  Where a woman has a smear taken during the attendance the COLPOSCOPY PRIME PROCEDURE TYPE should be recorded as classification 'No treatment; no treatment received and no biopsy taken'.

  Clinic Attendance Consultant and Clinic Attendance Nurse are both a CARE CONTACT where CARE CONTACT TYPE is National Code 06 'Clinic Attendance Consultant' and 10 'Clinic Attendance Nurse' respectively.

  For Clinic Attendance Consultant and Clinic Attendance Nurse, a first attendance is the first in a series of the only attendance at the clinic by a patient.

• The procedures undertaken in the colposcopy clinics are Patient Procedures. Only one Patient Procedure should be counted for each Clinic Attendance Consultant or Clinic Attendance Nurse. If more than one procedure is carried out, the most severe should be recorded for KC65.

  Patient Procedure is a CLINICAL INTERVENTION where CLINICAL INTERVENTION TYPE is National Code 25 'Patient Procedure'.

  Result of referral smear

• Lines 0001 to 0008 require data on the number of women referred for colposcopy by CYTOLOGY RESULT TYPES.

  Inadequate (line 0001)

• A count of the number of women with a CYTOLOGY RESULT TYPE classification of 'Inadequate sample (cat. 1)'.

  Borderline changes (line 0002)

• A count of the number of women with a CYTOLOGY RESULT TYPE classification of 'Borderline changes (cat. 8)'.

  Mild dyskaryosis (line 0003)

• A count of the number of women with a CYTOLOGY RESULT TYPE classification of 'Mild dyskaryosis (cat. 3)'.

  Moderate dyskaryosis (line 0004)

• A count of the number of women with a CYTOLOGY RESULT TYPE classification of 'Moderate dyskaryosis (cat. 7), including abnormal, unclassifiable and ungraded smears'.

  Severe dyskaryosis (line 0005)

• A count of the number of women with a CYTOLOGY RESULT TYPE classification of 'Severe dyskaryosis (cat. 4)'.

  Severe dyskaryosis/invasive carcinoma (line 0006)

• A count of the number of women with a CYTOLOGY RESULT TYPE classification of 'Severe dyskaryosis/invasive carcinoma (cat. 5)'.

  Glandular neoplasia (line 0007)

• A count of the number of women with a CYTOLOGY RESULT TYPE classification of 'Glandular neoplasia (cat. 6), including adenocarcinoma'.

  Referral Indication - Clinical indication (lines 0008, 0009)

• These columns count attendances for women with a REFERRAL REQUEST for colposcopy with a COLPOSCOPY REFERRAL INDICATION classification of 'Clinical indication'.

  Note all procedures carried out on women who have been referred to the colposcopy clinic with a REFERRAL REQUEST with a COLPOSCOPY REFERRAL INDICATION classification of 'Clinical indication' should be recorded in this line regardless of the result of any smear taken after the referral.

  Clinical Indication Urgent (line 0008)

• A count of the number of women with a COLPOSCOPY REFERRAL INDICATION classification of 'urgent'. This is restricted to cervical lesions suspicious of cancer, or post-coital bleeding of over four weeks where the patient is aged over 35.

  Clinical Indication Non-Urgent (line 0009)

• A count of the number of women with a COLPOSCOPY REFERRAL INDICATION classification of 'non-urgent'. This includes all other symptomatic referrals for colposcopy

  Other (line 0010)

• A count of the number of women with a CYTOLOGY RESULT TYPE classification of 'Other'.

  Entries recorded in Other (line 0010) should only occur in exceptional circumstances. NHS Cervical Screening Programme (NHSCSP) guidelines state that all smears should be identified as belonging to one of the eight recognised category classifications of CYTOLOGY RESULT TYPE. Other (line 0010) does not correspond to these recognised categories and should be used to record those rare cases in which a recognised category is not appropriate. Where an entry is present in Other (line 0010) then supporting notes should be recorded in the available box on the first page of the KC65 form.

  Total (line 0011)

• This is the total for all women counted in columns 2 to 8.

  No treatment (column 2)

• This counts the number of women who received no treatment and for whom was recorded a COLPOSCOPY PRIME PROCEDURE TYPE classification of 'No treatment; no treatment received and no biopsy taken'.

  Procedure Type

  Diagnostic biopsy (punch) (column 3)

• This counts the number of women who received no treatment and for whom a COLPOSCOPY PRIME PROCEDURE TYPE classification of 'Diagnostic biopsy (punch); no treatment received and biopsy type recorded as directed biopsy or multiple directed biopsy, or any other biopsy taken for diagnostic purposes only' was recorded.

  Treatment biopsy or treatment/diagnostic biopsy - Excision (column 4)

• This counts the number of women who for whom was recorded a COLPOSCOPY PRIME PROCEDURE TYPE classification of 'Loop/laser excision or knife cone; treatment method recorded as loop/laser excision or knife cone and biopsy type recorded as other than no biopsy. This will include LLETZ and NEEP'.

  Ablation + No Biopsy taken or biopsy result not yet known (column 5)

• This counts the number of women who for whom was recorded a COLPOSCOPY PRIME PROCEDURE TYPE classification of 'Ablation; treatment method recorded as ablation. This will include cold coagulation, Cryotherapy, cautery and diathermy. (ii) no biopsy taken, or biopsy result not known by clinic'.

  Ablation + Biopsy (column 6)

• This counts the number of women for whom COLPOSCOPY PRIME PROCEDURE TYPE classification of 'Ablation; treatment method recorded as ablation. This will include cold coagulation, Cryotherapy , cautery and diathermy. (i) biopsy result available' was recorded.

  Other (column 7)

• This counts the number of women for whom COLPOSCOPY PRIME PROCEDURE TYPE of 'Other; treatment method recorded as other and biopsy type recorded as other than no biopsy. This will include polyp avulsion and treatment with silver nitrate' was recorded. It excludes any treatment that is not related to cervical abnormalities.

  Number of first attendances (column 8)

• This is the total of all first attendances (see paragraph 2), subdivided by the CYTOLOGY RESULT TYPE classifications.

KC65 - Colposcopy Clinics: Referrals, Treatments and Outcomes

This return is in development by the NHS Cancer Screening Programme, therefore the information should not be used.
For the latest version of the form and further details, please see the Health and Social Care Information Centre website.For the latest version of the form and further details, please see the Health and Social Care Information Centre website.

• Part D - Cervical Biopsies, by time from biopsy to informing patient of result in writing

• Part D of the KC65 return shows for each cervical biopsy the time elapsing before the woman is informed in writing of the result. The NHS Cervical Screening Programme (NHSCSP) has issued guidance on waiting times, and the information is used to monitor whether clinics are meeting these standards. The return is based upon those biopsies taken during the first month of the quarter.

• The time measured in this part of the return is the interval between the PROCEDURE DATE of the colposcopy Patient Procedure at which the biopsy was taken and the Patient Informed Biopsy Result Date.

  Patient Procedure is a CLINICAL INTERVENTION where CLINICAL INTERVENTION TYPE is National Code 'Patient Procedure'. PROCEDURE DATE and Patient Informed Biopsy Result Date are both the same as attribute ACTIVITY DATE where ACTIVITY DATE TYPE is National Code 'Procedure Date' and 'Patient Informed Biopsy Result Date' respectively.

  Total biopsies in first month of quarter

• Column 2 counts the number of biopsies taken during the first month of the quarter. These are subdivided by the waiting times in lines 0001-0005.

  Less than or equal to 2 weeks (line 0001)

• This counts the number of women whose waiting time was less than or equal to 14 days.

  >2 weeks up to 4 weeks (line 0002)

• This counts the number of women whose waiting time was more than 14 days but less than or equal to 28 days.

  >4 weeks up to 8 weeks (line 0003)

• This counts the number of women whose waiting time was more than 28 days but less than or equal to 56 days.

  >8 weeks up to 12 weeks (line 0004)

• This counts the number of women whose waiting time was more than 56 days but less than or equal to 84 days.

  >12 weeks (line 0005)

• This counts the number of women whose waiting time was more than 84 days.

  Total (line 0006)

• This is the total for all women counted in column 2.

KC65: Colposcopy Clinics, Referrals, Treatments and Outcomes

This return is in development by the NHS Cancer Screening Programme, therefore the information should not be used.
For the latest version of the form and further details, please see the Health and Social Care Information Centre website.For the latest version of the form and further details, please see the Health and Social Care Information Centre website.

• Part E - Cervical Biopsies, by type and outcome

• Part E of KC65 shows the histological result BIOPSY REFERRAL OUTCOME for each cervical biopsy, which indicates whether cancer or a pre-cancerous condition has been identified from the sample taken. The information will help to monitor whether NHS Cervical Screening Programme (NHSCSP) guidance on the quality of biopsies and accuracy of diagnosis is being met.

• This part of the KC65 return is based upon those biopsies taken during the first month of the quarter. Please note that the total number of biopsies recorded in Part E should equal the total number recorded in Part D as both parts relate to the same biopsies.

• Column 5 counts the total number of BIOPSY REFERRAL OUTCOMES. These are analysed by biopsy type.

  Biopsy Type - Diagnostic (punch) (column 2)

• This counts the number of women for whom a COLPOSCOPY PRIME PROCEDURE TYPE classification of 'Diagnostic biopsy (punch); no treatment received and biopsy type recorded as directed biopsy or multiple directed biopsy or any other biopsy taken for diagnostic purposes only' was recorded.

  Biopsy Type - Excision (column 3)

• This counts the number of women for whom a COLPOSCOPY PRIME PROCEDURE TYPE classification of 'Loop/laser excision or knife cone; treatment method recorded as loop/laser excision or knife cone and biopsy type recorded as other than no biopsy. This will include LLETZ and NEEP.' was recorded.

  Biopsy Type - Other (column 3)

• This counts the number of women for whom a COLPOSCOPY PRIME PROCEDURE TYPE classification of other than 'Diagnostic biopsy (punch)', or 'Loop/laser excision or knife' was recorded.

  Outcome (Histology result)

• These results are further sub-divided by BIOPSY REFERRAL OUTCOME.

  Cancer (including micro-invasive) (line 0001)

• This counts women with a BIOPSY REFERRAL OUTCOME classification of 'Cancer (including micro-invasive)'.

  Adenocarcinoma in situ / CGIN (line 0002)

• This counts women with a BIOPSY REFERRAL OUTCOME classification of 'Adenocarcinoma in situ'.

  CIN3 (line 0003)

• This counts women with a BIOPSY REFERRAL OUTCOME classification of 'CIN3'.

  CIN2 (line 0004)

• This counts women with a BIOPSY REFERRAL OUTCOME classification of 'CIN2'.

  CIN1 (line 0005)

• This counts women with a BIOPSY REFERRAL OUTCOME classification of 'CIN1'.

  HPV/cervicitus only (line 0006)

• This counts women with a BIOPSY REFERRAL OUTCOME classification of 'HPV/cervicitus only'.

  No CIN/No HPV (line 0007)

• This counts women with a BIOPSY REFERRAL OUTCOME classification of 'No CIN/No HPV (normal)'.

  Inadequate / unsatisfactory biopsy (line 0008)

• This counts women with a BIOPSY REFERRAL OUTCOME classification of 'Inadequate/unsatisfactory biopsy'.

  Result not known by clinic (line 0009)

• This counts women with a BIOPSY REFERRAL OUTCOME classification of 'Result not known by clinic'.

  Total (line 0010)

• This is the total for all women counted in columns 2 to 5.

  Data Quality Checks

• The following data quality checks should be made:

  Part D	Part E
  Column 2 Line 006	= Column 4 Line 010

KT31 - Cross Sector Services

• Contextual Overview

• The Department of Health requires the collection of information about services provided by Sexual and Reproductive Health Clinics, in order to monitor the implementation of the Government's strategy to reduce the number of teenage pregnancies.

• Improving contraception and sexual health services and encouraging young people to seek advice are important aspects of the Teenage Pregnancy Strategy. Best Practice Guidance on the provision of effective contraception and advice services for young people was issued in November 2000 and Local Teenage Pregnancy Strategies all include proposals to ensure that appropriate services are in place.

• Monitoring of the Teenage Pregnancy Strategy is being undertaken partly through a National Indicator Set, which was issued in November 2001. This includes indicators on the provision of services in accordance with Best Practice Guidance and the uptake of services by under 18 year olds. The Central Return Form KT31 will provide data needed for these indicators.

• The Best Practice Guidance on service provision is concerned with services for young people under 25, and this is reflected in KT31:
  
  (i) A key goal of the Teenage Pregnancy Strategy is to reduce the rate of conceptions for under 18s. The AGE group is split into 16-17 year olds and 18-19 year olds in parts B and C of the form.

  (ii) An important part of the Teenage Pregnancy Strategy is to increase the awareness and involvement of young men in sexual health matters. Data on males is to be collected for exactly the same AGE groups as for females.

  Completing the Central Return KT31 Family Planning Services

• The coverage of the KT31 return includes services provided by NHS Trusts / Primary Care Trusts in Sexual and Reproductive Health Clinics and at Sexual and Reproductive Health Domiciliary Visits and also those provided by non-NHS clinics funded wholly or in part by the NHS. Not included are services provided by CONSULTANTS in Out-Patient Clinics or those provided by GENERAL MEDICAL PRACTITIONERS.

  Sexual and Reproductive Health Clinic and Out-Patient Clinic are both types of a CLINIC OR FACILITY. A Sexual and Reproductive Health Domiciliary Visit is a CARE CONTACT where the CARE CONTACT TYPE is National Code 22 Sexual and Reproductive Health Domiciliary Visit.

• A contact is a Clinic Attendance Sexual and Reproductive Health Service or a Sexual and Reproductive Health Domiciliary Visit, during which a PATIENT is seen by professional staff for counselling, or in order to be prescribed contraceptives.

  Clinic Attendance Sexual and Reproductive Health Service and Sexual and Reproductive Health Domiciliary Visit are both a CARE CONTACT where the CARE CONTACT TYPE is National Code  'Clinic Attendance Sexual and Reproductive Health Service' and  'Sexual and Reproductive Health Domiciliary Visit' respectively.

• A first contact in financial year is the first time a PATIENT is seen in the year by the Sexual and Reproductive Health Service. A subsequent contact with the same service provider does not count as a first contact, so each PATIENT is recorded only once in any year by any NHS Trust / Primary Care Trust.

• Where a couple are seen together only one first contact is recorded; where either vasectomy or the male condom is the main method chosen, the first contact is recorded as one with a man; in all other cases, where any other method is chosen, the first contact is recorded as one with a woman.

• The CONTRACEPTION METHOD MAIN for new PATIENTS is that chosen after counselling; for existing PATIENTS it is the principal method in use unless a change is advised. For new PATIENTS, the main method should be the substantive method chosen and not any interim method, even if the choice is not made until a subsequent attendance or visit. In particular, where vasectomy or female sterilisation is the method chosen after counselling, any interim methods used while waiting for an operation should not be recorded.

• The information in the KT31 Central Return form is submitted to the Health and Social Care Information Centre via the Omnibus Survey System. Further information can be found on the Health and Social Care Information Centre website.

• The information in the KT31 Central Return form is submitted to the Health and Social Care Information Centre via the Omnibus Survey System. Further information can be found on the Health and Social Care Information Centre website.